Health Economics & Value

Health Economics & Value
Product Description

Even if your objective seems clear–demonstrate the value of your product – it is rarely a simple task. That is because there is no single story or piece of evidence when you speak to audiences around the world: regulators, health technology assessment (HTA) bodies, payers, providers and patients. IQVIA accelerates your results while easing the complexity by developing health economic modelling solutions to support market-specific reimbursement, market access optimization, and high impact scientific publications. We can help you with our

  • International network to deliver local solutions with global oversight
  • Ability to leverage real-world evidence in HE modelling – access to the most comprehensive prescription and patient-level data available
  • Therapeutic and cross functional expertise (R&D, PMA, Epi etc.) for scientifically rigorous and commercially relevant HE solutions

IQVIA Ltd.

  • GB
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Consultancy
Specifications

IQVIA Ltd.

  • GB
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Consultancy

More Products from IQVIA Ltd. (6)

  • Managed Markets Data & Analytic Solutions

    Product Managed Markets Data & Analytic Solutions

    Fundamental to the success of your market access strategy is clear visibility into payer, provider and patient behavior. IQVIA’s comprehensive real-world database includes lifecycle transactions, which offer the critical level of detail required to untangle the complex interaction of payer utilization mana...
  • Brand and Promotional Analysis

    Product Brand and Promotional Analysis

    Powered by the IQVIA CORE™, our promotional analysis can help you understand the trajectory of your brand and measure its progress along the way. We can help you see where you are today, where you’re going and help you make adjustments as part of your path forward. Find out what you need to know about •...
  • Clinical Trial Optimization

    Product Clinical Trial Optimization

    Faster market access by optimized clinical trials Every study is unique and stakes are high. In order to ensure success IQVIA uses all available resources - therapeutical expertise, latest technology, advanced analytics and proactive approach. This allows us to effectively search for research centers an...
  • Launch Performance by Patient Segment

    Product Launch Performance by Patient Segment

    Each launch has a million moving pieces. Almost all are based on what you know about your market. Which patients are using which products? What is their patient journey? What types of physicians prescribe them? How do treatments and costs vary by geography or provider? Primary market research provides some...
  • Real-World Evidence Solutions

    Product Real-World Evidence Solutions

    Your work promises the potential to improve human outcomes. At IQVIA, we’re rethinking how to help you provide the complete understanding, tools, evidence, and communications to help you realize that potential. Innovating new study options. Applying advances in machine learning. Collaborating with provi...
  • Sales Force Effectiveness

    Product Sales Force Effectiveness

    Creating meaningful connections with physicians and group practices is essential to drive sales. But new regulatory guidelines and less time with physicians has made this increasingly difficult. Track the effectiveness of your sales team at a granular level, and develop new approaches to quickly and pre...

IQVIA Ltd. resources (2)

  • News CPHI Sustainability Trend Report: Towards a Greener Future

    CPHI releases its Sustainability Trend Report focusing on carbon emissions in the supply chain and working towards a greener future in the pharmaceutical industry.
  • Webinar Trends in Drug Delivery

    In this webinar, originally broadcast as part of the Pharmapack Europe show, speaker Aurelio Areas, Engagement Manager, IQVIA will give us a look at the global outlook of the pharma industry as it emerges from the pandemic with a focus on drug delivery trends. This session analyses current dynamics in drug delivery devices and look at emerging growth areas such as the rise of self-administration, connectivity and the impact of devices on our environment.